The Effect of Appropriate Family Companionship on the Physical and Mental Health of Patients With Advanced Breast Cancer
1 other identifier
interventional
304
1 country
1
Brief Summary
The goal of this clinical trial is to learn about companionship needs in breast cancer patients who are pathologically or cytologically diagnosed as cancer, are alive with the tumor, and have TNM clinical stage IV. The main questions it aims to answer are:
- 1.Patients with advanced breast cancer need family companionship
- 2.Analyze and study the reasons and factors that affect the physical and mental impact of effective family companionship on patients with advanced breast cancer Participants will be divided into a companion group and a non-accompaniment group. Patients in the companion group are given graded companion intervention methods. A comparison group: Researchers will compare a non-accompaniment group to see if the physical and mental impact of companionship on patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable breast-cancer
Started Apr 2024
Shorter than P25 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 26, 2023
CompletedStudy Start
First participant enrolled
April 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 22, 2024
CompletedFirst Posted
Study publicly available on registry
April 26, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedApril 26, 2024
December 1, 2023
Same day
December 26, 2023
April 25, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Change from Baseline meatal state on GAD-7 at Week 48.
The GAD-7 is a validated, self-reported instrument assessing average mental state intensify over the past 24 hour period. Possible scores range from 0 to 21.Change = (Week 48 Score - Baseline Score)
Baseline and Week 48
Change from Baseline physical state on kps at Week 48.
The kps is a validated, self-reported instrument assessing physical state average intensify over the past 24 hour period. Possible scores range from 0 to 100.Change = (Week 48 Score - Baseline Score)
Baseline and Week 48
Study Arms (2)
accompanying group
EXPERIMENTALnon-accompanied group
NO INTERVENTIONInterventions
Accompanying levels are divided into beginner, intermediate and advanced
Eligibility Criteria
You may qualify if:
- Breast cancer patients who are pathologically or cytologically diagnosed as cancer
- TNM clinical stage IV
You may not qualify if:
- Terminal cancer patients who are mentally ill or confused and refuse to participate in the survey
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Xin Penglead
Study Sites (1)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, 430022, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Deyin Hu, PhD
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Deputy chief nurse
Study Record Dates
First Submitted
December 26, 2023
First Posted
April 26, 2024
Study Start
April 22, 2024
Primary Completion
April 22, 2024
Study Completion
December 31, 2024
Last Updated
April 26, 2024
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will share